Envy Medical Announces New Lumixyl® Revitaleyes Brightening Eye Cream
WESTLAKE VILLAGE, Calif., Nov. 30, 2011 /PRNewswire/ -- Envy Medical Inc., announced the launch of the Lumixyl Revitaleyes Brightening Eye Cream, the latest addition to the Lumixyl Topical Brightening System of products for an even skin tone and a brighter, healthier complexion.
(Photo: http://photos.prnewswire.com/prnh/20111130/NY14300)
What makes Lumixyl Revitaleyes special? It is the first and only eye cream formulated with decapeptide-12 as part of a truly comprehensive treatment to correct dark circles, eye-area lines and wrinkles, dryness and inflammation. Most other products tackle just one or two of these issues, leaving behind unresolved problems. First introduced in the popular Lumixyl Brightening Creme, decapeptide-12 is the Stanford University developed technology that is clinically shown to reduce the appearance of hyperpigmentation in skin without causing the irritation or redness associated with other brands. Combined with other potent ingredients, Lumixyl Revitaleyes addresses all of the major contributing factors to dark circles under the eyes. The result is brightness, smoothness, and firmness that is truly age defying.
"Physicians and their patients have been telling us that they don't have good options for treating dark under-eye circles," says Curtis A. Cluff, Chief Executive Officer of Envy Medical, Inc. "We realized that there was no single product that comprehensively addressed the issues in a safe and effective manner. Envy Medical is in a unique position to do just that using the Lumixyl peptide technology as part of a comprehensive formulation to diminish under-eye circles, no matter what the contributing factors are."
"Our formula pairs industry proven ingredients that help with dermal iron deposits and inflammation with our proprietary skin brightening decapeptide-12 technology, making Revitaleyes the most comprehensive, professional-strength treatment for dark under-eye circles on the market today," states Felipe Jimenez, Ph.D., Chief Scientific Officer for Envy Medical.
In fact, Lumixyl Revitaleyes Brightening Eye Cream expertly addresses the six biggest eye-area complaints, including:
| SYMPTOM |
ACTIVE INGREDIENT |
| Hyperpigmentation |
Decapeptide–12 (Lumixyl peptide) – Reduces overproduction of skin pigment to brighten around the eyes |
| Iron Deposits |
Chrysin, N-Hydroxysuccinimide, EDTA – Removes discoloration caused by iron deposits in skin tissue around the eyes |
| Inflammation |
Dipotassium Glycyrrhizate – Inflammation casts a shadow around the eyes. This botanical anti-inflammatory naturally reduces this type of darkness |
| Dry Lines |
Glycerin, Butyrospermum Parkii (Shea) Butter, Sodium Hyaluronate — Promotes smooth texture and reduces the appearance of fine-line wrinkles |
| Wrinkles |
Palmitoyl Oligopeptide, Palmitoyl Tetrapeptide-7, Bambusa Vulgaris Extract, Pisum sativum (Pea) Extract–A powerful anti-aging cocktail that reduces the appearance of crepiness around eyes |
These proven potent ingredients are together for the first time, delivering improved eye lift, tone, texture and vitality never before achieved by a standard eye cream. The product will be sold through dermatology, cosmetic surgery and medical spa physicians throughout the United States. Suggested retail price is $65.00 per 0.5 oz tube. For more information go to www.Lumixyl.com, or contact [email protected].
ABOUT ENVY MEDICAL — Envy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company's lead products include SilkPeel®, a breakthrough device combining exfoliation with Dermalinfusion™ for deeper tissue delivery of active ingredients and better patient outcomes. Envy is also the exclusive licensor of skin brightening peptides including Lumixyl, developed at Stanford University. The Lumixyl peptide is now also available as a topical solution for SilkPeel procedures, addressing hyperpigmentation and photo-damage. More information can be found at www.envymedical.com.
SOURCE Envy Medical Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article